Effectiveness of Depression and Substance Use Module for Patients With Co-occurring Disorders

A total of 50 male participants aged 17 to 56 years admitted to a rehabilitation facility are enrolled in this parallel-group interventional study.

The research is structured as follows:

1. Pre-Assessment Screening: All participants are initially screened using the Beck Depression Inventory (BDI-II) to assess depression levels and the Drug Abuse Screening Test (DAST-10) to assess substance use severity.
2. Group Assignment: Participants are allocated to either the experimental group or the control group. The experimental group undergoes the designated treatment module (D-SUD-M) over a 12-session course spanning approximately 5 months (22 weeks). The control group undergoes routine rehabilitation facility program care without the specific D-SUD-M intervention.
3. Post-Assessment Screening: Following the completion of the intervention period at 22 weeks, both groups are re-evaluated using the exact same screening instruments (BDI-II and DAST-10) to statistically analyze symptom reduction and measure module effectiveness.

• Experimental Group: Treatment Module D-SUD-M (Behavioral): A specialized psychological Intervention based module design for reducing the symptoms and to check the effectiveness of module on patients with depression and substance use disorder. This module is translated and culturally adapted. A manual treatment booklet was written in which eclectic approaches were used like Behaviour therapy, Cognitive behaviour therapy, relapse prevention, group therapy along with activity sheets for each session. 12 intervention based sessions will be given to the participants of this group.
• Control Group (Behavioral): No module based treatment will be given to the participants of this group.

Primary outcomes

• Change in symptoms severity of depression from baseline to post-intervention [Baseline to Post-intervention (5months) total weeks(22)]: Assessed using the Beck Depression Inventory (BDI-II). The BDI-II is a 21-item self-report scale measuring characteristics and symptoms of depression. Total scores range from 0 to 63, with higher scores indicating a worse outcome (greater depressive symptom severity).
• Change in Substance Use Disorder Severity from baseline to post-intervention [baseline to post-intervention (5months), total weeks (22)]: Assessed using the Drug Abuse Screening Test (DAST-10). The DAST -10 is a self-report instrument used to evaluate consequences related to drug misuse. Total scores range from 0 to 10, with higher scores indicating a worse outcome (greater severity of substance use-related problems).

Sex: Male, ages: 17 Years to 56 Years

Inclusion Criteria:

1. Participants identified by the rehabilitation centre
2. Only male participants will be taken,
3. Age range lies between 17 to 56 years,
4. Screening of depression by using the Beck Depression Inventory (BDI-II) and for Substance Use Disorders using Drug Abuse Screening Test (DAST-10),
5. Diagnosed patients based on DSM-5 clinical diagnostic criteria will be taken into study.

Exclusion Criteria:

1. Diagnosed cases of other psychopathology including bipolar disorder, psychotic depression, and others will not be taken in study,
2. Cases of cognitive impairment linked to physical illness will not be part of the study.